Citigroup’s Loxo Oncology, Inc LOXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-54,619
| Closed | -$7.65M | – | 5277 |
|
|
2018
Q4 | $7.65M | Buy |
54,619
+48,333
| +769% | +$6.77M | 0.01% | 810 |
|
|
2018
Q3 | $1.07M | Sell |
6,286
-3,953
| -39% | -$675K | ﹤0.01% | 1952 |
|
|
2018
Q2 | $1.78M | Buy |
10,239
+9,485
| +1,258% | +$1.65M | ﹤0.01% | 1534 |
|
|
2018
Q1 | $87K | Buy |
754
+62
| +9% | +$7.15K | ﹤0.01% | 3459 |
|
|
2017
Q4 | $58K | Sell |
692
-1,453
| -68% | -$122K | ﹤0.01% | 3726 |
|
|
2017
Q3 | $198K | Sell |
2,145
-6,204
| -74% | -$573K | ﹤0.01% | 2981 |
|
|
2017
Q2 | $670K | Sell |
8,349
-3,543
| -30% | -$284K | ﹤0.01% | 2248 |
|
|
2017
Q1 | $501K | Buy |
11,892
+1,344
| +13% | +$56.6K | ﹤0.01% | 2406 |
|
|
2016
Q4 | $339K | Buy |
10,548
+9,383
| +805% | +$302K | ﹤0.01% | 3211 |
|
|
2016
Q3 | $30K | Sell |
1,165
-248
| -18% | -$6.39K | ﹤0.01% | 3992 |
|
|
2016
Q2 | $33K | Sell |
1,413
-6,227
| -82% | -$145K | ﹤0.01% | 3926 |
|
|
2016
Q1 | $209K | Buy |
7,640
+4,765
| +166% | +$130K | ﹤0.01% | 3441 |
|
|
2015
Q4 | $82K | Buy |
2,875
+2,874
| +287,400% | +$82K | ﹤0.01% | 3721 |
|
|
2015
Q3 | $0 | Sell |
1
-209
| -100% | – | ﹤0.01% | 5774 |
|
|
2015
Q2 | $4K | Buy |
210
+13
| +7% | +$248 | ﹤0.01% | 5000 |
|
|
2015
Q1 | $3K | Sell |
197
-423
| -68% | -$6.44K | ﹤0.01% | 5178 |
|
|
2014
Q4 | $7K | Buy |
620
+493
| +388% | +$5.57K | ﹤0.01% | 4971 |
|
|
2014
Q3 | $2K | Buy |
+127
| New | +$2K | ﹤0.01% | 5192 |
|